Correlation analysis between TBL2 expression levels and clinical pathological staging revealed that patients in the high TBL2 expression group had a later T‐stage (P = 0.024) and a higher tumor local recurrence rate (Local recurrence defined as a relapse on either chest wall or in a regional lymph node or distant recurrence) (P < 0.001) compared to those in the low TBL2 expression group (Figure 2B). Here, TBL2 is linked to neoplasm.